Access links:
CONTENT
Destacados
News
- 12/03/2013
Death rates of 60% of people infected by the virus that causes AIDS equals that of the general population
- The Institute for AIDS Research IrsiCaixa, funded by “la Caixa” Foundation and the Health Department of the Generalitat de Catalunya, has...
- 18/12/2012
Discovered how the AIDS virus enters key immune cells
Scientists from the AIDS Research Institute IrsiCaixa, funded by “la Caixa” Foundation and the Health Department of the government Generalitat de Catalunya (the autonomous Catalan government),...
- 28/11/2012
UNAIDS reports a more than 50% drop in new HIV infections across 25 countries
The number of people with access to antiretroviral therapy increased by 63% in the last 24 months—AIDS-related deaths fell by more than 25% between 2005 and 2011 globally.The new UNAIDS report is...
- 25/09/2012
HIVACAT has been licensed by the CSIC to develop a vaccine against HIV
The HIVACAT program for the development of this vaccine today announced the obtention of a license to advance in the development of a possible vaccine against HIV —the virus that causes AIDS. The...
- 24/04/2012
A new HIV molecule responsible for the dissemination of the virus throughout the body has been discovered
Scientists from the IrsiCaixa Institute for AIDS Research, promoted jointly by the Obra Social “la Caixa” and the Department of Health of the Generalitat de Catalunya, have discovered a component...
- 09/01/2012
IrsiCaixa describes new natural HIV-controlling mechanisms that the AIDS vaccine will have to induce
The IrsiCaixa Aids Research Institute, jointly promoted by the “la Caixa” Foundation and the Health Department of the Generalitat de Catalonia, has described some very effective immune response...
- 01/12/2011
IrsiCaixa and “la Caixa” Foundation launch a scientific dissemination and prevention program on AIDS for young people, which contributes to a reduced risk of infection
The IrsiCaixa AIDS Research Institute is presenting, together with “la Caixa” Foundation, a scientific dissemination and prevention program on AIDS aimed at secondary school students, which is...
- 22/09/2011
HIVACAT to host the AIDS Vaccine 2013, the most prestigious international congress that focuses on AIDS vaccine research
The Catalan Program for AIDS Vaccine Research, HIVACAT, has been selected to host AIDS Vaccine 2013, the largest and most prestigious international congress focusing exclusively on HIV vaccine...
- 21/09/2011
IrsiCaixa, the Autonomous University of Barcelona and Harvard University set up a pioneer postgraduate programme in AIDS
The IrsiCaixa Institute for AIDS Research and the Autonomous University of Barcelona (UAB) have reached an agreement to cooperate with Harvard University Medical School of Boston, the Harvard...
- 19/09/2011
HIVACAT identifies candidate to HIV vaccine and initiates animal experimentation
HIVACAT has identified several protein fragments with high potential to stimulate an effective immune response against HIV.This finding has required studies in over 1,000 patients and has allowed...
